Fatimah S. Dawood

Fatimah S. Dawood

Auto-generated profile, based on publicly available information

Fatimah S. Dawood

Centers for Disease Control and Prevention , Atlanta, Georgia , USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SGShikha Garg
Shikha Garg
SJSeema Jain
Seema Jain
FDFatimah S. Dawood
Fatimah S. Dawood
MJMichael Jhung
Michael Jhung
APAlejandro Pérez
Alejandro Pérez
LFLyn Finelli
Lyn Finelli
Influenza and pneumonia combined are the leading causes of death due to infectious diseases in the United States. We describe factors associated with pneumonia among adults hospitalized with influenza. Through the Emerging Infections Program, we identified adults ≥ 18 years, who were hospitalized with laboratory-confirmed influenza during October 2005 through April 2008, and had a chest radiograph (CXR) performed. Pneumonia was defined as the presence of a CXR infiltrate and either an ICD-9-CM code or discharge summary diagnosis of pneumonia. Among 4,765 adults hospitalized with influenza, 1392 (29 %) had pneumonia. In multivariable analysis, factors associated with pneumonia included: age ≥ 75 years, adjusted odds ratio (AOR) 1.27 (95 % confidence interval 1.10–1.46), white race AOR 1.24 (1.03–1.49), nursing home residence AOR 1.37 (1.14–1.66), chronic lung disease AOR 1.37 (1.18–1.59), immunosuppression AOR 1.45 (1.19–1.78), and asthma AOR 0.76 (0.62–0.92). Patients with pneumonia were significantly more likely to require intensive care unit (ICU) admission (27 % vs. 10 %), mechanical ventilation (18 % vs. 5 %), and to die (9 % vs. 2 %). Pneumonia was present in nearly one-third of adults hospitalized with influenza and was associated with ICU admission and death. Among patients hospitalized with influenza, older patients and those with certain underlying conditions are more likely to have pneumonia. Pneumonia is common among adults hospitalized with influenza and should be evaluated and treated promptly.

26 October 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
AKAnand Krishnan
Anand Krishnan
RARitvik Amarchand
Ritvik Amarchand
VGVivek Gupta
Vivek Gupta
KLKathryn E. Lafond
Kathryn E. Lafond
RSRizwan Abdulkader Suliankatchi
Rizwan Abdulkader Suliankatchi
MWMarc-Alain Widdowson
Marc-Alain Widdowson
Despite acute respiratory infections being a major cause of death among children in developing countries including India, there is a lack of community-based studies that document its burden and aetiology. A dynamic cohort of children aged 0–10 years was established in four villages in a north Indian state of Haryana from August 2012 onwards. Trained health workers conducted weekly home visits to screen children for acute respiratory infection (ARI) defined as one of the following: cough, sore throat, nasal congestion, earache/discharge, or breathing difficulty. Nurses clinically assessed these children to grade disease severity based on standard age-specific guidelines into acute upper or lower respiratory infection (AURI or ALRI) and collected nasal/throat swabs for pathogen testing. Our first year results show that ARI incidence in 0–10 years of age was 5.9 (5.8–6.0) per child-year with minimal gender difference, the ALRI incidence in the under-five age group was higher among boys (0.43; 0.39–0.49) as compared to girls (0.31; 0.26–0.35) per child year. Boys had 2.4 times higher ARI-related hospitalization rate as compared to girls. ARI impose a significant burden on the children of this cohort. This study platform aims to provide better evidence for prevention and control of pneumonia in developing countries.

7 April 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SPSamuel K Peasah
Samuel K Peasah
DPDebjani Ram Purakayastha
Debjani Ram Purakayastha
PKParvaiz Koul
Parvaiz Koul
FDFatima S Dawood
Fatima S Dawood
SSSiddhartha Saha
Siddhartha Saha
AKAnand Krishnan
Anand Krishnan
Despite the high mortality and morbidity resulting from acute respiratory infections (ARI) globally, there are few data from low-income countries on costs of ARI to inform public health policy decisions We conducted a prospective survey to assess costs of ARI episodes in selected primary, secondary, and tertiary healthcare facilities in north India where no respiratory pathogen vaccine is routinely recommended. Face-to-face interviews were conducted among a purposive sample of patients with ARI from healthcare facilities. Data were collected on out-of-pocket costs of hospitalization, medical consultations, medications, diagnostics, transportation, lodging, and missed work days. Telephone surveys were conducted two weeks after medical encounters to ask about subsequent missed work and costs incurred. Costs of prescriptions and diagnostics in public facilities were supplemented with WHO-CHOICE estimates of hospital bed costs. Missed work days were assigned cost based on the national annual per capita income (US$1,104). Non-medically attended ARI cases were identified from an ongoing community-based ARI surveillance project in Faridabad. During September 2012-March 2013, 1766 patients with ARI were enrolled, including 451 hospitalized patients, 1056 outpatients, and 259 non-medically attended patients. The total direct cost of an ARI episode requiring outpatient care was US$4- $6 for public and $3-$10 for private institutions based on age groups. The total direct cost of an ARI episode requiring hospitalized care was $54-$120 in public and $135-$355 in private institutions. The cost of ARI among those hospitalized was highest among persons aged > = 65 years and lowest among children aged < 5 years. Indirect costs due to missed work days were 16-25% of total costs. The direct out-of-pocket cost of hospitalized ARI was 34% of annual per capita income. The cost of hospitalized ARI episodes in India is high relative to median per capita income. Data from this study can inform evaluations of the cost effectiveness of proven ARI prevention strategies such as vaccination.

1 February 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
RHRachel Holstein
Rachel Holstein
FDFatimah S. Dawood
Fatimah S. Dawood
AOAlissa O’hAlloran
Alissa O’hAlloran
CCCharisse Cummings
Charisse Cummings
DUDawud Ujamaa
Dawud Ujamaa
SGShikha Garg
Shikha Garg
Pregnant women may be at increased risk for severe influenza-associated outcomes. This repeated cross-sectional analysis of data from the U.S. Influenza Hospitalization Surveillance Network sought ... Visual Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019. Pregnant women may be at increased risk for severe influenza-associated outcomes. This repeated cross-sectional... Background: Pregnant women may be at increased risk for severe influenza-associated outcomes. Objective: To describe characteristics and outcomes of hospitalized pregnant women with influenza. Desi...

22 April 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
RKRuth A. Karron
Ruth A. Karron
MQMaria Garcia Quesada
Maria Garcia Quesada
ESElizabeth A. Schappell
Elizabeth A. Schappell
SSStephen D. Schmidt
Stephen D. Schmidt
MKMaria Deloria Knoll
Maria Deloria Knoll
FDFatimah S. Dawood
Fatimah S. Dawood
Background: SARS-CoV-2 infections are frequently milder in children than adults, suggesting that immune responses may vary with age. However, information is limited regarding SARS-CoV-2 immune responses in young children. Methods: We compared receptor binding domain–binding antibody (RBDAb) titers and SARS-CoV-2–neutralizing antibody titers, measured by pseudovirus-neutralizing antibody assay in serum specimens obtained from children aged 0–4 years and 5–17 years and in adults aged 18–62 years at the time of enrollment in a prospective longitudinal household study of SARS-CoV-2 infection. Results: Among 56 seropositive participants at enrollment, children aged 0–4 years had more than 10-fold higher RBDAb titers than adults (416 vs. 31, P < 0.0001) and the highest RBDAb titers in 11 of 12 households with seropositive children and adults. Children aged 0–4 years had only 2-fold higher neutralizing antibody than adults, resulting in higher binding-to-neutralizing antibody ratios compared with adults (2.36 vs. 0.35 for ID 50 , P = 0.0004). Conclusion: These findings suggest that young children mount robust antibody responses to SARS-CoV-2 following community infections. Additionally, these results support using neutralizing antibody to measure the immunogenicity of COVID-19 vaccines in children aged 0–4 years. Funding: CDC (award 75D30120C08737).

12 April 2022 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
ARAnnette Regan
Annette Regan
MWMeredith G. Wesley
Meredith G. Wesley
MGManjusha Gaglani
Manjusha Gaglani
SKSara S. Kim
Sara S. Kim
LELaura J. Edwards
Laura J. Edwards
HGHolly Groom
Holly Groom
Background: Healthcare personnel (HCP) are a priority group for annual influenza vaccination. Few studies have assessed the validity of recall of prior influenza vaccination status among HCP, especially for more than one preceding season.Methods: Using data from a randomized controlled trial of influenza vaccination among 947 HCP from two US healthcare systems, we assessed agreement between participant self‐report and administrative record documentation of influenza vaccination status during the preceding five influenza seasons; kappa coefficients and sensitivity values were calculated. Administrative record documentation was considered the gold standard. Documented vaccination sources included electronic medical records, employee health records, outside immunization providers, and the state immunization information system.Results: Among 683 HCP with prior influenza immunization information, 89.7% (95% CI: 87.2%, 91.9%) of HCP were able to self‐report their vaccination status for the season preceding the survey. By the fifth preceding season, 82.6% (95% CI: 79.5%, 85.3%) of HCP were able to self‐report. Among HCP who self‐reported their vaccination status, agreement between self‐report and documented vaccination status ranged from 81.9% (95% CI: 77.2%, 86.7%) for the fifth season to 90.5% (95% CI: 87.2%, 93.9%) for the season preceding interview. HCP who received vaccine for only some of the preceding five seasons (18.3%) more commonly had ≥2 errors in their recall compared with those vaccinated all five preceding seasons (55.7% vs. 4.3%).Conclusions: Self‐reported vaccination status is a reliable source for historical influenza vaccination information among HCP who are consistently vaccinated but less reliable for those with a history of inconsistent vaccination.